China Medical System Holdings Limited Stock

Stocks

867

KYG211081248

Pharmaceuticals

OTC Markets Traded
Market Closed - Hong Kong S.E. 04:08:30 2026-06-11 am EDT 5-day change 1st Jan Change
10.82 HKD -0.46% Intraday chart for China Medical System Holdings Limited +0.84% -16.12%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: China Medical System Holdings Limited

Market Cap 22.75B 26.31B 3.36B 2.91B 2.68B 2.51B 4.68B 320B 4.78B 31.83B 12.34B 155B 12.6B 12.33B 539B P/E Ratio 2026 *
11.2x
P/E Ratio 2027 * 9.56x
Enterprise Value 20.32B 23.51B 3B 2.6B 2.39B 2.24B 4.18B 286B 4.27B 28.44B 11.03B 138B 11.26B 11.02B 481B EV / Sales 2026 *
2.06x
EV / Sales 2027 * 1.71x
Free-Float
51.73%
Yield 2026 *
3.92%
Yield 2027 * 4.42%
Jun. 08 China Medical System Holdings Limited Presents Preclinical Results of Self-Developed Innovative INHBE-Targeting siRNA Drug CMS-D008 At ADA Scientific Sessions CI
May. 29 China Medical System Holdings Limited commences an Equity Buyback Plan for 243,952,851 shares, representing 10% of its issued share capital, under the authorization approved on April 23, 2026. CI
May. 25 China Medical System says NPMA approved CMS-D001 granted drug clinical trial RE
May. 25 China Medical System Gets China Trial Approval for Crohn's, Colitis Drug MT
Apr. 23 China Medical System Holdings Limited Approves Final Dividend for the Year Ended December 31, 2025 CI
Apr. 23 China Medical System Gets China Acceptance for Seasonal Allergic Rhinitis Drug Indication of MG-K10 MT
Apr. 23 China Medical System Holdings Limited Announces Acceptance of New Drug Application for Seasonal Allergic Rhinitis Indication of Mg-K10 in China CI
Mar. 17 China Medical System's Profit Slides in 2025 MT
Mar. 17 China Medical System posts FY turnover up 9.9% to RMB8,212.1 million RE
Mar. 16 China Medical System Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Mar. 16 China Medical System posts profit for year RMB1,443.3 million RE
Mar. 16 China Medical System Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2025, Payable on About 7 May 2026 CI
Mar. 16 China Medical System Holdings Limited Appoints Luo Laura Ying as Member of the Environment, Social and Governance Committee, Effective from 16 March, 2026 CI
1 day-0.46%
1 week+0.84%
Current month+2.27%
1 month-12.10%
3 months-19.55%
6 months-20.50%
Current year-16.12%
1 week 10
Extreme 10
10.95
1 month 10
Extreme 10
12.8
Current year 10
Extreme 10
15.52
1 year 10
Extreme 10
15.63
3 years 6.23
Extreme 6.23
15.86
5 years 6.23
Extreme 6.23
21.85
10 years 6.14
Extreme 6.14
22.8
Manager TitleAgeSince
Chief Executive Officer 61 2020-03-30
Director of Finance/CFO 55 -
Chief Investment Officer 50 2021-12-31
Director TitleAgeSince
Chairman 61 2006-12-17
Director/Board Member 55 2006-12-17
Director/Board Member 60 2017-12-12
Date Insider Type Main position Quantity % Market Cap.
24-09-22Other

Chief Executive Officer

500,000 0.0205%
24-09-19Other

Chief Executive Officer

500,000 0.0205%
24-09-16Other

Chief Executive Officer

500,000 0.0205%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%+0.84%-1.28%-10.28% 3.36B
+2.24%+3.54%+44.08%+161.63% 1,013B
+0.55%+5.30%+54.74%+50.25% 574B
+0.35%+0.58%+18.15%+64.27% 397B
-0.37%+4.97%+21.24%+15.95% 324B
+0.70%+0.10%+24.41%+14.69% 280B
+2.07%+5.04%+25.44%+33.95% 273B
+3.55%+0.97%+19.58%+60.54% 182B
-0.19%-0.46%-45.32%-48.35% 194B
+3.49%-2.62%+15.09%+61.56% 151B
Average +1.22%+2.51%+17.61%+40.42% 339.2B
Weighted average by Cap. +1.39%+3.99%+29.78%+73.01%

Financials

2026 *2027 *
Net sales 9.86B 11.41B 1.46B 1.26B 1.16B 1.09B 2.03B 139B 2.07B 13.8B 5.35B 67.15B 5.46B 5.35B 234B 11.63B 13.46B 1.72B 1.49B 1.37B 1.28B 2.39B 164B 2.45B 16.28B 6.31B 79.22B 6.45B 6.31B 275B
Net income 2.02B 2.34B 298M 258M 238M 223M 415M 28.41B 425M 2.83B 1.1B 13.76B 1.12B 1.1B 47.84B 2.38B 2.76B 352M 305M 281M 263M 490M 33.53B 501M 3.34B 1.29B 16.24B 1.32B 1.29B 56.47B
Net Debt -2.42B -2.8B -357M -309M -285M -267M -498M -34.05B -509M -3.39B -1.31B -16.49B -1.34B -1.31B -57.35B -2.89B -3.35B -427M -369M -341M -319M -595M -40.67B -608M -4.05B -1.57B -19.69B -1.6B -1.57B -68.49B
Logo China Medical System Holdings Limited
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
Employees
6,415
Date Price Change Volume
26-06-11 10.82 $ -0.46% 3,252,070
26-06-10 10.87 $ +5.53% 4,203,000
26-06-09 10.30 $ -0.48% 6,352,712
26-06-08 10.35 $ -2.82% 7,670,744
26-06-05 10.65 $ +0.95% 2,981,000
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
9.397CNY
Average target price
15.52CNY
Spread / Average Target
+65.16%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!